4.6 Article

Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Fatigue in Prostate Cancer Survivors Treated With Definitive Radiotherapy and LHRH Analogs

Anne E. Kyrdalen et al.

PROSTATE (2010)

Article Health Care Sciences & Services

Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical Trial

Elyse E. Lower et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)

Review Clinical Neurology

Safety of therapeutic methylphenidate in adults: a systematic review of the evidence

J. Godfrey

JOURNAL OF PSYCHOPHARMACOLOGY (2009)

Article Oncology

Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases

Olav Lindqvist et al.

EUROPEAN JOURNAL OF ONCOLOGY NURSING (2008)

Review Oncology

A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue

Ollie Minton et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)

Article Hospitality, Leisure, Sport & Tourism

Benefits of a physical activity intervention for men with prostate cancer

S. Nicole Culos-Reed et al.

JOURNAL OF SPORT & EXERCISE PSYCHOLOGY (2007)

Article Oncology

Pharmacologic treatment of cancer-related fatigue

Jennifer K. Carroll et al.

ONCOLOGIST (2007)

Article Medicine, General & Internal

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

IF Tannock et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Oncology

Resistance exercise in men receiving androgen deprivation therapy for prostate cancer

RJ Segal et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)